1. Home
  2. GHRS vs WGO Comparison

GHRS vs WGO Comparison

Compare GHRS & WGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GHRS
  • WGO
  • Stock Information
  • Founded
  • GHRS 2018
  • WGO 1958
  • Country
  • GHRS Ireland
  • WGO United States
  • Employees
  • GHRS N/A
  • WGO N/A
  • Industry
  • GHRS Biotechnology: Pharmaceutical Preparations
  • WGO Homebuilding
  • Sector
  • GHRS Health Care
  • WGO Industrials
  • Exchange
  • GHRS Nasdaq
  • WGO Nasdaq
  • Market Cap
  • GHRS 874.0M
  • WGO 893.6M
  • IPO Year
  • GHRS 2021
  • WGO N/A
  • Fundamental
  • Price
  • GHRS $12.22
  • WGO $34.32
  • Analyst Decision
  • GHRS Strong Buy
  • WGO Buy
  • Analyst Count
  • GHRS 8
  • WGO 11
  • Target Price
  • GHRS $30.63
  • WGO $39.60
  • AVG Volume (30 Days)
  • GHRS 183.0K
  • WGO 460.3K
  • Earning Date
  • GHRS 08-07-2025
  • WGO 10-22-2025
  • Dividend Yield
  • GHRS N/A
  • WGO 3.88%
  • EPS Growth
  • GHRS N/A
  • WGO N/A
  • EPS
  • GHRS N/A
  • WGO N/A
  • Revenue
  • GHRS N/A
  • WGO $2,741,800,000.00
  • Revenue This Year
  • GHRS N/A
  • WGO N/A
  • Revenue Next Year
  • GHRS N/A
  • WGO $5.92
  • P/E Ratio
  • GHRS N/A
  • WGO N/A
  • Revenue Growth
  • GHRS N/A
  • WGO N/A
  • 52 Week Low
  • GHRS $6.00
  • WGO $28.00
  • 52 Week High
  • GHRS $20.50
  • WGO $65.65
  • Technical
  • Relative Strength Index (RSI)
  • GHRS 37.28
  • WGO 49.68
  • Support Level
  • GHRS $13.71
  • WGO $33.81
  • Resistance Level
  • GHRS $14.59
  • WGO $35.28
  • Average True Range (ATR)
  • GHRS 0.73
  • WGO 1.08
  • MACD
  • GHRS -0.09
  • WGO -0.29
  • Stochastic Oscillator
  • GHRS 4.62
  • WGO 16.54

About GHRS GH Research PLC

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.

About WGO Winnebago Industries Inc.

Winnebago Industries manufactures Class A, B, and C motor homes along with towables, customized specialty vehicles, boats, and parts. Headquartered in Eden Prairie, Minnesota, Winnebago has been producing recreational vehicles since 1958. Revenue was nearly $3 billion in fiscal 2024. Winnebago expanded into towables in 2011 with the acquisition of SunnyBrook and acquired Grand Design in November 2016. Towables made up 83% of the firm's RV unit volume, up from 31% in fiscal 2016. The company's total RV unit volume was 38,796 in fiscal 2024. Winnebago expanded into boating in 2018 with the purchase of Chris-Craft, bought premium motor home maker Newmar in November 2019, and bought Barletta pontoon boats in August 2021. It also is developing electric and autonomous technology.

Share on Social Networks: